TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 0.330nMAssay Description:Antagonist activity at human P2X7 receptor expressed in HEK293 cells assessed as inhibition of BzATP-induced calcium mobilization monitored for 5 min...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 0.330nMAssay Description:Antagonist activity at human P2X7 receptor expressed in HEK293 cells assessed as inhibition of BzATP-induced calcium mobilization monitored for 5 min...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 0.790nMAssay Description:Antagonist activity at human P2X7 receptor expressed in HEK293 cells assessed as inhibition of BzATP-induced calcium mobilization monitored for 5 min...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 0.790nMAssay Description:Antagonist activity at human P2X7 receptor expressed in HEK293 cells assessed as inhibition of BzATP-induced calcium mobilization monitored for 5 min...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 1.30nMAssay Description:Antagonist activity at human recombinant P2X7 receptor expressed in HEK293 cells assessed as inhibition of ATP-induced calcium mobilization incubated...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 1.30nMAssay Description:Antagonist activity at human recombinant P2X7 receptor expressed in HEK293 cells assessed as inhibition of ATP-induced calcium mobilization incubated...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 1.5nMAssay Description:Antagonist activity at human recombinant P2X7 receptor expressed in HEK293 cells assessed as inhibition of ATP-induced calcium mobilization incubated...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 1.5nMAssay Description:Antagonist activity at human recombinant P2X7 receptor expressed in HEK293 cells assessed as inhibition of ATP-induced calcium mobilization incubated...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 2.40nMAssay Description:Antagonist activity at human recombinant P2X7 receptor expressed in 1321N1 cells assessed as inhibition of BzATP-induced calcium mobilization incubat...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 2.40nMAssay Description:Antagonist activity at human recombinant P2X7 receptor expressed in 1321N1 cells assessed as inhibition of BzATP-induced calcium mobilization incubat...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 2.70nMAssay Description:Antagonist activity at human recombinant P2X7 receptor expressed in 1321N1 cells assessed as inhibition of BzATP-induced calcium mobilization incubat...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 2.70nMAssay Description:Antagonist activity at human recombinant P2X7 receptor expressed in 1321N1 cells assessed as inhibition of BzATP-induced calcium mobilization incubat...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 3.20nMAssay Description:Antagonist activity at human recombinant P2X7 receptor expressed in HEK293 cells assessed as inhibition of ATP-induced calcium mobilization incubated...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 3.20nMAssay Description:Antagonist activity at human recombinant P2X7 receptor expressed in HEK293 cells assessed as inhibition of ATP-induced calcium mobilization incubated...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 3.40nMAssay Description:Antagonist activity at human recombinant P2X7 receptor expressed in HEK293 cells assessed as inhibition of ATP-induced calcium mobilization incubated...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 3.40nMAssay Description:Antagonist activity at human recombinant P2X7 receptor expressed in HEK293 cells assessed as inhibition of ATP-induced calcium mobilization incubated...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 3.90nMAssay Description:Antagonist activity at human recombinant P2X7 receptor expressed in HEK293 cells assessed as inhibition of ATP-induced calcium mobilization incubated...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 3.90nMAssay Description:Antagonist activity at human recombinant P2X7 receptor expressed in HEK293 cells assessed as inhibition of ATP-induced calcium mobilization incubated...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 4.5nMAssay Description:Antagonist activity at human recombinant P2X7 receptor expressed in 1321N1 cells assessed as inhibition of BzATP-induced calcium mobilization incubat...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 4.5nMAssay Description:Antagonist activity at human recombinant P2X7 receptor expressed in 1321N1 cells assessed as inhibition of BzATP-induced calcium mobilization incubat...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 6.90nMAssay Description:Antagonist activity at human recombinant P2X7 receptor expressed in 1321N1 cells assessed as inhibition of BzATP-induced calcium mobilization incubat...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 6.90nMAssay Description:Antagonist activity at human recombinant P2X7 receptor expressed in 1321N1 cells assessed as inhibition of BzATP-induced calcium mobilization incubat...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 8.5nMAssay Description:Antagonist activity at human recombinant P2X7 receptor expressed in 1321N1 cells assessed as inhibition of BzATP-induced calcium mobilization incubat...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 8.5nMAssay Description:Antagonist activity at human recombinant P2X7 receptor expressed in 1321N1 cells assessed as inhibition of BzATP-induced calcium mobilization incubat...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 8.5nMAssay Description:Antagonist activity at human recombinant P2X7 receptor expressed in 1321N1 cells assessed as inhibition of BzATP-induced calcium mobilization incubat...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 8.5nMAssay Description:Antagonist activity at human recombinant P2X7 receptor expressed in 1321N1 cells assessed as inhibition of BzATP-induced calcium mobilization incubat...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 8.70nMAssay Description:Antagonist activity at human recombinant P2X7 receptor expressed in 1321N1 cells assessed as inhibition of BzATP-induced calcium mobilization incubat...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 8.70nMAssay Description:Antagonist activity at human recombinant P2X7 receptor expressed in 1321N1 cells assessed as inhibition of BzATP-induced calcium mobilization incubat...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: <10nMAssay Description:Antagonist activity at human P2X7 receptor expressed in HEK293 cells assessed as inhibition of BzATP-induced pore formation incubated for 20 mins fol...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: <10nMAssay Description:Antagonist activity at human P2X7 receptor expressed in HEK293 cells assessed as inhibition of BzATP-induced pore formation incubated for 20 mins fol...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Rattus norvegicus (Rat))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 10nMAssay Description:Antagonist activity at rat P2X7 receptor expressed in 1321N1 cells assessed as inhibition of BzATP-induced calcium mobilization incubated for 30 mins...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: <10nMAssay Description:Antagonist activity at human P2X7 receptor expressed in THP1 cells assessed as inhibition of BzATP-induced IL-1beta release preincubated for 20 mins ...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: <10nMAssay Description:Antagonist activity at human P2X7 receptor expressed in THP1 cells assessed as inhibition of BzATP-induced IL-1beta release preincubated for 20 mins ...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: <10nMAssay Description:Antagonist activity at human P2X7 receptor expressed in HEK293 cells assessed as inhibition of BzATP-induced pore formation incubated for 20 mins fol...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: <10nMAssay Description:Antagonist activity at human P2X7 receptor expressed in THP1 cells assessed as inhibition of BzATP-induced IL-1beta release preincubated for 20 mins ...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: <10nMAssay Description:Antagonist activity at human P2X7 receptor expressed in THP1 cells assessed as inhibition of BzATP-induced IL-1beta release preincubated for 20 mins ...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Rattus norvegicus (Rat))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 10nMAssay Description:Antagonist activity at rat P2X7 receptor expressed in 1321N1 cells assessed as inhibition of BzATP-induced calcium mobilization incubated for 30 mins...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: <10nMAssay Description:Antagonist activity at human P2X7 receptor expressed in HEK293 cells assessed as inhibition of BzATP-induced pore formation incubated for 20 mins fol...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 11nMAssay Description:Antagonist activity at human recombinant P2X7 receptor expressed in 1321N1 cells assessed as inhibition of BzATP-induced calcium mobilization incubat...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 11nMAssay Description:Antagonist activity at human recombinant P2X7 receptor expressed in 1321N1 cells assessed as inhibition of BzATP-induced calcium mobilization incubat...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 11nMAssay Description:Antagonist activity at human recombinant P2X7 receptor expressed in 1321N1 cells assessed as inhibition of BzATP-induced calcium mobilization incubat...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 11nMAssay Description:Antagonist activity at human recombinant P2X7 receptor expressed in 1321N1 cells assessed as inhibition of BzATP-induced calcium mobilization incubat...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Rattus norvegicus (Rat))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 17nMAssay Description:Antagonist activity at rat P2X7 receptor expressed in 1321N1 cells assessed as inhibition of BzATP-induced calcium mobilization incubated for 30 mins...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Rattus norvegicus (Rat))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 17nMAssay Description:Antagonist activity at rat P2X7 receptor expressed in 1321N1 cells assessed as inhibition of BzATP-induced calcium mobilization incubated for 30 mins...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Rattus norvegicus (Rat))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 17nMAssay Description:Antagonist activity at rat P2X7 receptor expressed in 1321N1 cells assessed as inhibition of BzATP-induced calcium mobilization incubated for 30 mins...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Rattus norvegicus (Rat))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 17nMAssay Description:Antagonist activity at rat P2X7 receptor expressed in 1321N1 cells assessed as inhibition of BzATP-induced calcium mobilization incubated for 30 mins...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 18nMAssay Description:Antagonist activity at human P2X7 receptor expressed in HEK293 cells assessed as inhibition of BzATP-induced calcium mobilization incubated for 30 mi...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 18nMAssay Description:Antagonist activity at human P2X7 receptor expressed in HEK293 cells assessed as inhibition of BzATP-induced calcium mobilization incubated for 30 mi...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 19nMAssay Description:Antagonist activity at human recombinant P2X7 receptor expressed in 1321N1 cells assessed as inhibition of BzATP-induced calcium mobilization incubat...More data for this Ligand-Target Pair
TargetP2X purinoceptor 7(Homo sapiens (Human))
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Janssen Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 19nMAssay Description:Antagonist activity at human recombinant P2X7 receptor expressed in 1321N1 cells assessed as inhibition of BzATP-induced calcium mobilization incubat...More data for this Ligand-Target Pair